Chang-Chun Ling

Dr. Chang-Chun Ling is a Professor in the Department of Chemistry at the University of Calgary, affiliated with the Arnie Charbonneau Cancer Institute. He holds a PhD from the Université de Paris Sud (1991) and completed postdoctoral research in Dublin, Paris, and Edmonton. His research focuses on bioorganic chemistry, carbohydrate-based vaccines, glycosyltransferase inhibitors, and neuroinflammation modulation. He leads projects at the Alberta Glycomics Centre targeting infectious diseases and cancer.

• Education:
• B.S. Chemistry, University of Lanzhou, 1986
• PhD Chemistry, Université de Paris Sud, 1991

Research interests include carbohydrate-protein interactions, synthetic carbohydrate chemistry, and glycoconjugate vaccines. His lab explores inhibitors for tumor-associated enzymes, conjugate vaccine design, and ECM-driven neuroinflammation in multiple sclerosis and stroke. Key achievements include developing fluorinated glycans for myelin regeneration and cyclodextrin-based liquid crystal electrolytes.

Notable awards include the Alberta/Pfizer Translational Research Fund Award (2013) and Alberta Ingenuity New Faculty Award (2007). Current projects involve multidisciplinary approaches to combat multidrug-resistant infections and autoimmune conditions.